2022年1月,細胞治療有關的市場研究報告 “Global Cell Freezing Media for Cell Therapy
Professional Survey Report 2022, Forecast to 2027”已正式發佈,報告用於細胞治療專業市場的整個細胞冷凍培養基的前景,包括全球銷售和收入預測、區域預測。 它還按類型和應用預測了用於細胞治療專業市場的細胞冷凍培養基。
研究報告提及部份出色的行業參與者,如下
* BioLife Solutions
* Thermo Fisher Scientific
* Merck
* GE Healthcare
* Zenoaq
* WAK-Chemie Medical
* Biological Industries
* Akron Biotechnology
是次全面的市場研究報告,相信可以幫助客戶保持更新並在他們的業務中做出有效的決策。
Other news
同根同夢 · 2025 全球華人春節聯歡晚會暨楷模人物年度盛典
In view of extraordinary influence in the biotechnological industry, our CEO, James Chan was sincerely
1 月
亞洲最有價值品牌大獎2024
Hong Kong Weike Biotechnology Company Limited was awarded “Most Trusted Biotechnology Solutions Of The Year” of Asia’s
9 月
Scientific Annual Report of CELLBANKERs (2023)
・ The number of citations in 2023 was 266 and reached record high. ・The number of
5 月
2023年度最傑出生物技術產品
Hong Kong Weike Biotechnology Company Limited was awarded「年度最傑出生物技術產品」of the HKCT Business Awards 2023 held by
9 月
Global Cell Freezing Media for Cell Therapy Professional Survey Report
A report titled, “Global Cell Freezing Media for Cell Therapy Professional Survey Report 2022, Forecast
4 月
CELLBANKER’s Scientific Annual Report (2021)
ZENOAQ has issued publications on research of cell cryopreserved regularly. Here is the summary for
2 月